Search

SOLGENT

SOLGENT

HomeManufacturers
OverviewProduct ListData Room

Introduction

For the past 19 years, SolGent grown as a company specialized in human molecular diagnostics projects. In celebration of its 20th anniversary, the company announced its vision of a new start, “SolGent 2.0” and is growing as a bio leader in the 4th Industrial Revolution.

Sturdily amassed genome analysis technology and molecular diagnostic technology have become the prominent foundation of the molecular diagnostic market, and SolGent supply products and services with the highest quality to more than 25 countries including domestic research institutes, examination centers, medical institutions and universities.

In particular, as “precision medicine,” which analyzes genomes to prevent and predict diseases, becomes a new medical paradigm, SolGent develops and supplies various genome analysis services including for cancer, and expands and applies these services to agricultural products to build the AG-BIO platform. Based on its innovative technology, SolGent develops NADPH coenzyme fixed quantity measurement products


DiaPlexQ™ Novel Coronavirus (2019-nCoV) Detection Kit, Covid19, Corona virus

Location

43-10, Techno 5-ro, Yuseong-gu, Daejeon, Korea

http://www.solgent.com/

+82-42-864-5695

+82-42-864-5690

global@solgent.com

조회수130
SOLGENT

SOLGENT

CEO  Charlie ParkCorporate #  535-86-00664
Ace Dongbaek Tower 1-1101, 16-4, Dongbaekjungang-ro 16beon-gil, Giheung-gu, Yongin City, Gyeonggido, South Korea    (Post Code 17015)

ⓒ2023 Komachine Inc. All rights reserved.